Workers, students and the population of all Cuban provinces will pay tribute this Monday to their heroes in the context of the Camilo-Che Commemorative Days, which will be held until October 28.

After receiving the authorization of the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) and the approval of the Ministry of Public Health, a phase II-III clinical trial began at the Institute of Hematology and Immunology, aimed at evaluating the safety, immunogenicity and efficacy of a new version of the Cuban anti-pneumococcal vaccine Quimio-Vio, in adults from 50 to 74 years of age.

Cuban Prime Minister Manuel Marrero held talks today with companies from the United Arab Emirates (UAE) interested in commercializing Cuban biotechnological products, such as Heberprot-P and Melagenia Plus.